Fan W, Yanase T, Morinaga H, Okabe T, Nomura M, Daitoku H, et al
Early diagnosis and standard DKA management are key to preventing serious outcomes
These medications have been extensively studied and are FDA approved for weight management and blood sugar control
Saaga M, Sobczak M, Fichna J (2013) Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract
Zepbound ( tirzepatide ) takes this one step further by activating not only the GLP-1 receptor but also the GIP receptor, which may enhance its effects on both weight reduction and blood sugar control
Maintaining adequate hydration is important, as dehydration from gastrointestinal symptoms can increase the risk of acute kidney injury